Baidu Ventures portfolio company Qitan Technology has pulled in $14.1m to progress its pathogen detection technology for drug development and diagnostics.
Qitan Technology, a China-based gene sequencing device developer backed by internet group Baidu, raised more than RMB100m ($14.1m) in series A funding yesterday.
The round was led by venture capital firm Gaorong Capital and also featured Yinxinggu Capital and Alwin Capital.
Founded in 2016, Qitan is working on pathogen detection systems for use in drug development, cancer diagnosis and pathology. The series A cash will be used for research and development and the expansion of its manufacturing capabilities as it…
